Tonix Pharmaceuticals Holding Corp.
TNXP
$15.52
$0.301.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.22% | -68.00% | 23.88% | -55.55% | 81.96% |
| Total Depreciation and Amortization | -4.55% | -2.03% | -49.28% | 90.59% | -43.65% |
| Total Amortization of Deferred Charges | -- | -100.00% | 123.55% | -232.06% | -51.28% |
| Total Other Non-Cash Items | -61.17% | 86.28% | 712.57% | -72.23% | -97.90% |
| Change in Net Operating Assets | -91.69% | 325.96% | -151.15% | 196.85% | -237.48% |
| Cash from Operations | -94.04% | 10.53% | -13.32% | 22.18% | -89.55% |
| Capital Expenditure | -82.54% | -8,683.33% | -100.00% | 66.67% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Investing | 62.11% | -42,216.67% | -100.00% | 66.67% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -1,268.79% | 0.00% | 0.00% |
| Issuance of Common Stock | 580.39% | -77.70% | -27.65% | 94.46% | 268.73% |
| Repurchase of Common Stock | 100.00% | 4.76% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -514.58% | 78.55% | 31.13% | -47.27% | 52.42% |
| Cash from Financing | 762.92% | -77.81% | -41.83% | 98.47% | 510.75% |
| Foreign Exchange rate Adjustments | 0.00% | 55.56% | -137.50% | 241.18% | -1,800.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,120.10% | -119.38% | -53.31% | 192.99% | 932.28% |